Skip to content

8-KAccepted Feb 22, 8:30 AM ET

Ambrx Biopharma, Inc. 8-K

Ambrx Biopharma, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

8:30 AM

Feb 22, 2024

Filed

Feb 22, 2024

Documents

12

Size

156.9 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.